cancer-immunotherapy

Documents about cancer-immunotherapy

• Immunogenic tumor mass dormancy as a driver of persistent residual lesions in immunotherapy-treated melanoma#435613bioRxiv / medRxiv
• Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC#651244ClinicalTrials.gov
• Study of Personalized Immunotherapy in Adults With Metastatic Colorectal Cancer#849027ClinicalTrials.gov
• Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)#332767ClinicalTrials.gov
• A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy#830790ClinicalTrials.gov
• Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer#394753ClinicalTrials.gov
• Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease#121355ClinicalTrials.gov
• Association Of Immune Checkpoint Inhibitor Approval On Suicide Rates Among Patients With Cancer: A Pre-Post Analysis With Seer#167490EliScholar
• Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols#201759ClinicalTrials.gov
• QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management#201788ClinicalTrials.gov
• A comprehensive analysis of humanized mouse models for the study of cancer immunotherapies#280257HAL (France)
• QL1706 Plus Neoadjuvant Chemotherapy Followed by Type I Hysterectomy for Locally Advanced Cervical Cancer#283049ClinicalTrials.gov
• Distant antimestastatic effect of enterotropic colon cancer-derived a4b7+ CD8+ T cells#326171HAL (France)
• Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer#454013ClinicalTrials.gov
• Artificial intelligence (AI)-enabled platforms for cancer vaccine engineering#781946ULRR
• Acupuncture Combined With PD-1/PD-L1 Inhibitors for Advanced Lung Cancer#836097ClinicalTrials.gov
• Investigator Initiated Phase 1 Study of TBI-1301#803168ClinicalTrials.gov
• SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC#832936ClinicalTrials.gov
• Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial#481743ClinicalTrials.gov
• Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy#125813ClinicalTrials.gov
• First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy#158205ClinicalTrials.gov
• ATM regulates differentiation of myofibroblastic cancer-associated fibroblasts and can be targeted to overcome immunotherapy resistance#190599Southampton
• Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC#201760ClinicalTrials.gov
• Circulating cell populations as response predictors and targets to improve immunotherapy in metastatic lung cancer.#281034NCBI PubMed Central
• NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors#314341ClinicalTrials.gov
• Immunotherapy does not impair ovarian function in a mouse model of breast cancer.#378512NCBI PubMed Central
• 68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC#411396ClinicalTrials.gov
• Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)#411407ClinicalTrials.gov
• A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)#414359ClinicalTrials.gov
• Role of Renal Biopsy in the Suspicion of Nephrotoxicity of Immunotherapy (Checkpoint Inhibitors) in Solid Cancer#426771ClinicalTrials.gov
• Global research trends on the gut microbiota and immunotherapy for colorectal cancer: a bibliometric analysis.#452825NCBI PubMed Central
• Rational design and biological validation of EZH2/PD-L1 bifunctional inhibitors for colorectal cancer immunotherapy.#455390NCBI PubMed Central
• Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer#481754ClinicalTrials.gov
• EZH1/2 inhibition improves immunotherapy response through MHC Class II de-repression and neutrophil reprogramming#619186bioRxiv / medRxiv
• An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread#651233ClinicalTrials.gov
• Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy#665380HAL (France)
• Current landscape and future directions of neoantigen vaccines: A new era of personalized cancer immunotherapy.#678305NCBI PubMed Central
• Pilot Study of DRibble Vaccine for Prostate Cancer Patients#810964ClinicalTrials.gov
• Systematic Evaluation of Human Explant Model Systems Engineering#830069ClinicalTrials.gov
• STM-06: POLARIS-POlymetastic Lesion Ablative Radiotherapy With Immunotherapy Study#863443ClinicalTrials.gov
• AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.#201768ClinicalTrials.gov
• Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC#300261ClinicalTrials.gov
• Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer#272341ClinicalTrials.gov
• ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy#366614ClinicalTrials.gov
• Application and mechanistic research of novel therapeutic strategies in cisplatin-resistant small cell lung cancer#4521Europe PMC
• Effect of G-CSF on MDSC and Cancer Stem-cells Interactions in Non-small Cell Lung Cancers (CIRCUIT)#121328ClinicalTrials.gov
• Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment#123443ClinicalTrials.gov
• Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients#123448ClinicalTrials.gov
• Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)#136324ClinicalTrials.gov
• Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis#253004ClinicalTrials.gov